Concord Drugs share news and announcements
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹69.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 43.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,703
Concord Drugs board meetings
127 filed, newest first. Page 2 of 3.
Sep 2023
7 Sep · Board meeting
Aug 2023
7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
May 2023
9 May · Board meeting
Meeting on 30 May 2023: audited results
Apr 2023
14 Apr · Board meeting
Mar 2023
28 Mar · Board meeting
Meeting on 28 Mar 202328 Mar · Board meeting
27 Mar · Board meeting
16 Mar · Board meeting
Meeting on 27 Mar 2023
Feb 2023
14 Feb · Board meeting
2 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Nov 2022
14 Nov · Board meeting
7 Nov · Board meeting
3 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Sep 2022
7 Sep · Board meeting
5 Sep · Board meeting
Meeting on 7 Sep 2022: preferential issue of shares
Aug 2022
13 Aug · Board meeting
6 Aug · Board meeting
Jul 2022
28 Jul · Board meeting
Meeting on 6 Aug 2022: quarterly results
May 2022
17 May · Board meeting
Meeting on 30 May 2022: audited results6 May · Board meeting
Meeting on 6 May 20226 May · Board meeting
Feb 2022
14 Feb · Board meeting
Jan 2022
28 Jan · Board meeting
Meeting on 14 Feb 2022: quarterly results
Oct 2021
8 Oct · Board meeting
Meeting on 18 Oct 2021: quarterly results
Aug 2021
13 Aug · Board meeting
2 Aug · Board meeting
Meeting on 13 Aug 2021: quarterly results
Jun 2021
16 Jun · Board meeting
Meeting on 28 Jun 2021: audited results
Jan 2021
28 Jan · Board meeting
Meeting on 13 Feb 2021: quarterly results
Dec 2020
4 Dec · Board meeting
Nov 2020
4 Nov · Board meeting
Meeting on 13 Nov 2020: quarterly results
Sep 2020
4 Sep · Board meeting
Meeting on 14 Sep 2020: quarterly results
Jun 2020
17 Jun · Board meeting
Meeting on 27 Jun 2020: audited results
Jan 2020
31 Jan · Board meeting
Meeting on 13 Feb 2020: quarterly results